The effect of post-operative nasal packing on mucociliary activity

ISRCTN ISRCTN27163398
DOI https://doi.org/10.1186/ISRCTN27163398
Secondary identifying numbers N0025107235
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
31/03/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Tristram Hugh John Lesser
Scientific

Otolaryngology
University Hospital Aintree
Longmoor Lane
Liverpool
L9 7AL
United Kingdom

Study information

Study designProspective randomised controlled pilot study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleThe effect of post-operative nasal packing on mucociliary activity
Study objectivesWe expect that nasal packs disrupt the nasal mucosal membrane for up to 3 months causing increased morbidity.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedEar, Nose and Throat: Post-operative nasal packing
InterventionPatients will be randomised to receive either Merocel, Vasolene gauze or no packs. The effect on the mucociliary transport will be assessed by performing a saccharin clearance test pre-operatively, after removal of packs prior to discharge and at subsequent clinic follow-up. It is envisaged that the packs will significantly alter the mucociliary transport time, leading to increased post-operative morbidity. This will lead to an alteration in departmental policy and fewer patients will be packed as a result. Data analysis of the results to assess the mucociliary transport rates will be done.
Intervention typeProcedure/Surgery
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/09/2001
Completion date01/06/2003

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants40 ENT patients
Key inclusion criteriaNot provided at time of registration
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/09/2001
Date of final enrolment01/06/2003

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University Hospital Aintree
Liverpool
L9 7AL
United Kingdom

Sponsor information

Department of Health (UK)
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.doh.gov.uk

Funders

Funder type

Hospital/treatment centre

Aintree Hospitals NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

31/03/2020: No publications found, all search options exhausted, study status unverified.